Quarterly report pursuant to Section 13 or 15(d)

Discontinued Operations - Schedule of Discontinued Operation of Balance Sheet and Operation Statement (Details)

v3.10.0.1
Discontinued Operations - Schedule of Discontinued Operation of Balance Sheet and Operation Statement (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Dec. 31, 2017
Cash $ 9,999   $ 9,999   $ 17,554
Accounts receivable, net 179,864   179,864   179,737
Prepaid expenses and other current assets 35,777   35,777   29,441
Current assets classified as held for sale 225,640   225,640   226,732
Property and equipment, net 8,619   8,619   21,078
Deposits 6,029   6,029   7,756
Non-current assets classified as held for sale 14,648   14,648   28,834
Accounts payable (includes related parties) 986,433   986,433   1,078,965
Accrued expenses 861,261   861,261   644,300
Current portion of notes payable 281,728   281,728   249,589
Current liabilities classified as held for sale 2,129,422   2,129,422   1,972,854
Revenue from services 345,424 $ 512,566 1,383,378 $ 1,336,877  
Cost of services 55,860 45,641 133,738 132,010  
Gross profit 289,564 466,925 1,249,640 1,204,867  
Operating expenses 1,285,990 625,950 1,940,990 3,937,258  
Other (income) expenses 11,532 404 (807,137) 19,776  
Income/(Loss) from discontinued operations (1,007,957) (159,430) 115,787 (2,752,166)  
Advanced Molecular Services Group [Member]          
Cash 8,575   8,575   9,273
Accounts receivable, net 1,837   1,837   19,022
Prepaid expenses and other current assets 25,477   25,477   25,477
Current assets classified as held for sale 35,889   35,889   53,772
Accounts payable (includes related parties) 492,898   492,898   671,561
Accrued expenses 405,616   405,616   375,165
Current portion of notes payable 281,728   281,728   249,589
Current liabilities classified as held for sale 1,180,242   1,180,242   1,296,315
Revenue from services 13,249 1,120 92,090 224,224  
Cost of services 15,559 8,513 37,773 9,282  
Gross profit (2,310) (7,393) 54,317 214,942  
Operating expenses 93,059 328,233 363,944 1,225,639  
Other (income) expenses (5,748) 34,523 (819,258) 42,767  
Income/(Loss) from discontinued operations (89,621) (370,149) 509,631 (1,053,464)  
Health Technology Solutions, Inc [Member]          
Cash 1,424   1,424   8,281
Accounts receivable, net 178,027   178,027   160,715
Prepaid expenses and other current assets 10,300   10,300   3,964
Current assets classified as held for sale 189,751   189,751   172,960
Property and equipment, net 8,619   8,619   21,078
Deposits 6,029   6,029   7,756
Non-current assets classified as held for sale 14,648   14,648   28,834
Accounts payable (includes related parties) 493,535   493,535   407,404
Accrued expenses 455,645   455,645   269,135
Current liabilities classified as held for sale 949,180   949,180   $ 676,539
Revenue from services 499,317 344,304 1,291,288 1,112,653  
Cost of services 30,082 47,347 95,965 122,728  
Gross profit 469,235 296,957 1,195,323 989,925  
Operating expenses 532,892 957,757 1,577,046 2,711,619  
Other (income) expenses 6,152 (22,992) 12,121 (22,992)  
Income/(Loss) from discontinued operations $ (69,808) $ (637,808) $ (393,844) $ (1,698,702)